PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology

NCT05592665 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma

Interventions

OTHER: Survey Questionnaire

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

Doris Duke Charitable Foundation